Medicines Co. To Continue Battle Against Patent Office's Refusal To Extend Angiomax Patent Term
This article was originally published in The Pink Sheet Daily
Executive Summary
PTO rejects a district court's analysis of the Angiomax approval date and issues a harsh letter denying TMC's application for patent term extension.